51
Pharma & HealthcareHold
PGIM India Healthcare
PGIM India · Direct–Growth · rank #8 of 18 by Smart Score
Data updated
Trailing returns
1 Year
26.8%
+23.8% vs index
3 Years
—
5 Years
—
Since launch
14.4%
Year-by-year performance
2025
-1.0%-8.7% vs index
2026
+25.6%+27.6% vs index
Why this score
PGIM India Healthcare scores 51/100 — #8 of 18 Pharma & Healthcare fund (Hold). It stands out for volatility and alpha — beating 84% of peers on volatility. The main drag is its sharpe ratio (better than only 16% of peers).
Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.
Sharpe ratio0.60 · 16th percentile in category
Volatility13.15 · 84th percentile in category
Fund size111.64 Cr · 8th percentile in category
Alpha11.04 · 84th percentile in category
Expense ratio0.92% · 81st percentile in category
Sortino ratio0.82 · 17th percentile in category
Top holdings
1.Sun Pharmaceutical Industries Ltd10.86%
2.Divi's Laboratories Ltd10.35%
3.Torrent Pharmaceuticals Ltd9.38%
4.Aster DM Healthcare Ltd6.21%
5.Max Healthcare Institute Ltd5.86%
29 disclosed equity positions · portfolio as of Jul 2026 · weights are % of total corpus.